Dosing will be a critical milestone that many are waiting on.
RAC are now screening for patients which means the train has officially left the station, the next stop is first patient dosed which is when the science starts to turn real and the market should start paying attention.
Soon it'll no longer be dusty phase 3 data from decades ago, but clean cut RC220 data that will either validate the opportunity or show us the door. Huge psychological barrier is about to be broken (dosing).
RAC Price at posting:
$1.02 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)